secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2022-01-31T23:59:59+00:00
Accession:  0001213900-22-004373
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband receives US patent for AVERSA abuse deterrent transdermal technology
------------------------------------------------------------------------------

- USPTO issued patent for 'Abuse and Misuse Deterrent Transdermal System' covering AVERSA platform.
- Lead product AVERSA Fentanyl could be first abuse deterrent fentanyl transdermal system.
- Expanded pipeline includes AVERSA buprenorphine and AVERSA methylphenidate.
- Patents also granted in Europe, Japan, Korea, Russia, Mexico, Australia.
- CEO Gareth Sheridan calls it an important milestone for Nutriband.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390022004373/0001213900-22-004373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390022004373/ea154687-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-004373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer